Evidence map›Paper›PMID 25493600›Full record

Trial reportAIDS (London, England)2014

Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission.

Nicole L Davis, William C Miller, Michael G Hudgens, Charles S Chasela, Dorothy Sichali, Dumbani Kayira, Julie A E Nelson, Jeffrey S A Stringer, Sascha R Ellington, Athena P Kourtis and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. What is new in perinatal HIV prevention?Current opinion in pediatrics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nicole L DavisaDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina bDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina cDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA dDivision of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Parktown, South Africa eUniversity of North Carolina, UNC Project, Lilongwe, Malawi fDepartment of Microbiology and Immunology, School of Medicine; Center for AIDS Research, University of North Carolina gGlobal Women's Health Division, Department of Obstetrics & Gynecology; Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, North Carolina hDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
William C Miller
Michael G Hudgens
Charles S Chasela
Dorothy Sichali
Dumbani Kayira
Julie A E Nelson
Jeffrey S A Stringer
Sascha R Ellington
Athena P Kourtis
Denise J Jamieson
Charles van der Horst
BAN study team

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
UNC CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTIONU48DP001944 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2009 to 2013
$15.1M
UNC Center for Health Promotion and Disease PreventionU48DP000059 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2004 to 2009
$14.4M
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW001039 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 1998 to 2013
$9.9M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
ACL HHS U48DP001944FIC NIH HHS 2-D43 TW01039-06FIC NIH HHS D43 TW001039FIC NIH HHS R24 TW007988NCCDPHP CDC HHS U48 DP000059NCCDPHP CDC HHS U48-DP000059-01NCCDPHP CDC HHS U48-DP001944-01NIAID NIH HHS 5T32AI070114NIAID NIH HHS P30 AI050410NIAID NIH HHS P30-AI50410NIAID NIH HHS T32 AI070114PHS HHS U48-CCU409660-09
6 · The paper itself

Abstract

objectiveEstimate association between postpartum antiretroviral adherence and breast milk HIV-1 transmission.

designProspective cohort study.

methodsMother-infant pairs were randomized after delivery to immediately begin receiving 28 weeks of either triple maternal antiretrovirals (zidovudine, lamivudine, and either nevirapine, nelfinavir, or lopinavir-ritonavir) or daily infant nevirapine as part of the Breastfeeding, Antiretrovirals, and Nutrition (BAN) study. Associations between postpartum antiretroviral adherence and rate of breast milk HIV-1 transmission were estimated using Cox models. We measured adherence over four postpartum time intervals using pill count, suspension bottle weight, and maternal self-report. Adherence was categorized and lagged by one interval. Missing adherence measures were multiply imputed. Infant HIV-1 infection was determined by DNA PCR every 2-6 weeks. The primary endpoint was infant HIV-1 infection by 38 weeks of age among infants alive and uninfected at 5 weeks.

resultsAnalyses included 1479 mother-infant pairs and 45 transmission events. Using pill count and bottle weight information, 22-40% of mother-infant pairs at any given interval were less than 90% adherent. Having at least 90% adherence was associated with a 52% [95% confidence interval (CI) 3-76] relative reduction in the rate of breast milk HIV-1 transmission, compared with having less than 90% adherence when controlling for study arm, breastfeeding status, and maternal characteristics. Complete case analysis rendered similar results (n = 501; relative reduction 59%, 95% CI 6-82).

conclusionNonadherence to extended postpartum antiretroviral regimens in 'real world' settings is likely to be higher than that seen in BAN. Identifying mothers with difficulty adhering to antiretrovirals, and developing effective adherence interventions, will help maximize benefits of antiretroviral provision throughout breastfeeding.

Indexed as

Breast FeedingMedication AdherencePostpartum PeriodAdolescentAdultAnti-Retroviral AgentsCohort StudiesDisease Transmission, InfectiousFemaleHIV InfectionsHumansInfantInfant, NewbornMaleMiddle AgedMilk, HumanAnti-Retroviral Agents

Identifiers

PMID25493600
PMCPMC4397579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.